# National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)

> **NCT04760132** · PHASE4 · COMPLETED · sponsor: **Jens D Lundgren, MD** · enrollment: 7600 (actual)

## Conditions studied

- SARS-CoV Infection

## Interventions

- **BIOLOGICAL:** COMIRNATY - BioNTech Manufacturing GmbH
- **BIOLOGICAL:** COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH
- **BIOLOGICAL:** COVID-19 Vaccine AstraZeneca suspension for injection

## Key facts

- **NCT ID:** NCT04760132
- **Lead sponsor:** Jens D Lundgren, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-08
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 7600 (ACTUAL)
- **Last updated:** 2024-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04760132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04760132, "National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04760132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*